The disadvantage of CgA is that it can be false positive in chronic gastritis, inflammatory bowel disease, pancreatitis, renal or liver failure, other malignancies (thyroid and prostate cancer) or different therapies (proton pump inhibitors, somatostatin analogues or steroids) [1,7,18]. This evidence concerns the gene CGA and prostate carcinoma.